In a 77‑year‑old woman with hypertension on amlodipine 10 mg daily and losartan 100 mg daily who has uncontrolled systolic blood pressure in the 150 mm Hg range and cannot tolerate a thiazide diuretic because of urinary incontinence, what is the appropriate next antihypertensive agent to add?

Management of Uncontrolled Hypertension in a 77-Year-Old Woman

Direct Recommendation

Add chlorthalidone 12.5–25 mg once daily as your third antihypertensive agent to achieve guideline-recommended triple therapy (ARB + calcium-channel blocker + thiazide-like diuretic). 1

---

Rationale for Chlorthalidone Over Hydrochlorothiazide

• Chlorthalidone is strongly preferred over hydrochlorothiazide because it provides superior 24-hour blood pressure control (half-life 24–72 hours vs. 6–12 hours) and has robust cardiovascular outcome data from the ALLHAT trial. 2, 1
• The AHA Scientific Statement on Resistant Hypertension explicitly recommends thiazide-like diuretics (chlorthalidone or indapamide) over HCTZ due to more effective blood pressure lowering, particularly at night. 2
• In elderly patients specifically, chlorthalidone has demonstrated greater efficacy in achieving systolic blood pressure targets. 3

---

Why Not Alternative Agents

• Beta-blockers are not appropriate as a third agent in this patient without compelling indications (angina, post-MI, heart failure with reduced ejection fraction, or atrial fibrillation requiring rate control), as they are less effective than diuretics for stroke prevention and cardiovascular event reduction. 2, 1
• Spironolactone is reserved as a fourth-line agent if blood pressure remains ≥140/90 mmHg after optimized triple therapy; adding it now would skip the evidence-based stepwise approach. 1, 4
• Increasing current medication doses (e.g., losartan beyond 100 mg or amlodipine beyond 10 mg) is less effective than adding a third drug class from a complementary mechanism. 1

---

Addressing the Incontinence Concern

• The patient's urinary incontinence attributed to thiazide diuretics may have been related to hydrochlorothiazide's shorter duration of action causing more abrupt diuresis. 2
• Chlorthalidone's longer half-life produces more gradual, sustained diuresis that may be better tolerated regarding urinary frequency. 2, 1
• Dosing strategy to minimize incontinence: Start chlorthalidone 12.5 mg in the morning (not evening) and advise the patient to take it early (e.g., 7–8 AM) so peak diuretic effect occurs during waking hours. 1
• If incontinence recurs with chlorthalidone, consider spironolactone 25 mg daily as an alternative diuretic that has less pronounced urinary frequency effects while still addressing volume-dependent hypertension. 1, 4

---

Blood Pressure Targets and Monitoring

• Target blood pressure is <140/90 mmHg minimum, with an optimal goal of <130/80 mmHg if tolerated without adverse effects in this 77-year-old. 2, 1
• Reassess blood pressure within 2–4 weeks after adding chlorthalidone, with the goal of achieving target within 3 months of this medication change. 2, 1
• Check serum potassium and creatinine 2–4 weeks after initiating chlorthalidone to detect hypokalemia or changes in renal function, especially given concurrent losartan use. 2, 1

---

If Blood Pressure Remains Uncontrolled on Triple Therapy

• Add spironolactone 25–50 mg daily as the preferred fourth-line agent for resistant hypertension, which provides additional blood pressure reductions of approximately 20–25/10–12 mmHg when added to triple therapy. 1, 4
• Spironolactone addresses occult volume expansion and aldosterone escape that commonly underlie treatment resistance in elderly patients. 1, 4
• Monitor serum potassium closely (within 1–2 weeks) when adding spironolactone to losartan due to increased hyperkalemia risk. 1

---

Critical Steps Before Adding Medication

• Verify medication adherence first, as non-adherence is the most common cause of apparent treatment resistance; use direct questioning, pill counts, or pharmacy refill records. 2, 1
• Confirm true hypertension with home blood pressure monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) to exclude white-coat hypertension. 2, 1
• Review for interfering medications: NSAIDs, decongestants, oral contraceptives, systemic corticosteroids, and herbal supplements (ephedra, St. John's wort) can all elevate blood pressure. 1

---

Lifestyle Modifications (Adjunct to Pharmacotherapy)

• Sodium restriction to <2 g/day yields a 5–10 mmHg systolic reduction and enhances the efficacy of ARBs and diuretics. 2, 1
• Weight loss if overweight—losing approximately 10 kg reduces blood pressure by about 6.0/4.6 mmHg. 1
• DASH dietary pattern (high in fruits, vegetables, whole grains, low-fat dairy; low in saturated fat) lowers blood pressure by roughly 11.4/5.5 mmHg. 1
• Regular aerobic exercise (≥30 minutes most days, ≈150 minutes/week moderate intensity) reduces blood pressure by approximately 4/3 mmHg. 1
• Limit alcohol to ≤1 drink/day for women, as excess consumption interferes with blood pressure control. 1

---

Common Pitfalls to Avoid

• Do not add a beta-blocker as the third agent without compelling cardiac indications, as this violates guideline-recommended stepwise approaches and is less effective for stroke prevention. 2, 1
• Do not combine losartan with an ACE inhibitor (dual RAS blockade), as this increases adverse events (hyperkalemia, acute kidney injury) without additional cardiovascular benefit. 2, 1
• Do not delay treatment intensification—this patient has systolic blood pressure in the 150s requiring prompt action within 2–4 weeks to reduce cardiovascular risk. 2, 1
• Do not assume treatment failure without first confirming adherence and ruling out secondary causes of hypertension (primary aldosteronism, renal artery stenosis, obstructive sleep apnea). 2, 1

---

Special Considerations for Elderly Patients

• Elderly patients often have isolated systolic hypertension and volume-dependent mechanisms, making thiazide-like diuretics particularly effective. 3, 5
• Amlodipine pharmacokinetics show prolonged elimination half-life in elderly patients (64 vs. 48 hours in younger patients), but this does not require dose adjustment and may provide more sustained blood pressure control. 6
• The combination of losartan plus low-dose hydrochlorothiazide has shown higher percentages of elderly patients achieving blood pressure goals compared to younger patients. 3